Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EMA recommends orphan drug status for Aprea's APR-246 for AML

Feb. 24, 2010

Merrimack begins phase I/II trial of MM-121/Tarceva in NSCLC

Feb. 24, 2010

Roche reports on global phase III Avastin trial in stomach cancer

Feb. 24, 2010

Antibody-conjugated magnetic-vortex microdiscs induce cancer cell death in vitro

Feb. 24, 2010

Korean researchers discover novel antimitotic agents

Feb. 24, 2010

Bromotetrandrine well tolerated and slowly cleared in healthy volunteers

Feb. 24, 2010

Lilly, Merck and Pfizer form Asian Cancer Research Group

Feb. 23, 2010

Novel HSP90 inhibitors identified by sanofi-aventis

Feb. 23, 2010

Dual PI3K/mTOR inhibitor with potent preclinical antitumor activity enters phase I trial

Feb. 23, 2010

Genentech identifies novel Janus kinase inhibitors

Feb. 22, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...